The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jan. 14, 2025

Filed:

Jun. 14, 2018
Applicant:

Ludwig Institute for Cancer Research Ltd., New York, NY (US);

Inventors:

Immanuel F. Luescher, Gollion, CH;

Julien Schmidt, Peillonnex, FR;

Philippe Guillaume, Les Hopitaux Vieux, FR;

Danijel Dojcinovic, Epalinges, CH;

Assignee:
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 39/385 (2006.01); A61K 39/00 (2006.01); C07K 14/74 (2006.01); C07K 17/00 (2006.01); C12N 5/0783 (2010.01);
U.S. Cl.
CPC ...
C07K 17/00 (2013.01); A61K 39/00 (2013.01); A61K 39/385 (2013.01); C07K 14/70539 (2013.01); A61K 2039/605 (2013.01); A61K 2039/627 (2013.01); A61K 2039/64 (2013.01);
Abstract

Some aspect of this disclosure provide reversible MHC protein multimers, and methods of using such multimers in the detection and/or isolation of specific T-cells or T-cell populations. Because reversible MHC multimers can efficiently be dissociated, the time of MHC binding to T-cell receptors, and, thus, T-cell receptor-mediated T-cell activation can be minimized. The use of reversible MHC multimers as provided herein, accordingly, allows for the detection and isolation of bona fide antigen-specific CD8+ T cells without inducing activation dependent cell death, including rare, therapeutically valuable T-cells expressing T-cell receptors binding tumor antigens with high affinity. Methods for the production and use of reversible multimers are also provided.


Find Patent Forward Citations

Loading…